Poster: Gut microbiota and liver disease
General hepatology |
Short:
Number:
Room: Poster Area
Language: British English
Type: Poster
Number:
Room: Poster Area
Language: British English
Type: Poster
Presentations
Title | Time (CET) |
Add to Calendar |
Abstract | |||
---|---|---|---|---|---|---|
.1 |
THU189 Administration of lactobacillus alleviates experimental NASH by reducing miR-21 in the liver
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.2 |
THU190 Disease severity and proton pump inhibitor use impacts strongest on faecal microbiome composition in cirrhosis
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.3 |
THU192 Alteration of the gut microbiota in patients with primary sclerosing cholangitis and concomitant dominant strictures
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.4 |
THU193 Gut microbiota and metabolites associated with response to ursodesoxycholic acid in patients with primary biliary cholangitis
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.5 |
THU194 Gut microbiota are associated with minimal hepatic encephalopathy (MHE) in cirrhosis regardless of country of origin
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.6 |
THU195 Microbiota modulates ischemia-reperfusion injury in mouse liver transplantation
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.7 |
THU196 Gut microbiota composition is difference between HCV mono-infection and HCV/HIV co-infection
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.8 |
THU197 Transplantation of gut microbiota derived from MCJ-KO genotype determines a protective profile against non-alcoholic fatty liver disease in germ-free mice
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.9 |
THU198 Effects of anti-TNF? treatment on Crohn's disease induced hepatic steatosis
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.10 |
THU199 Investigation of microbiome metabolites and mitochondrial function in non-alcoholic fatty liver disease
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.11 |
THU200* Veillonella as a bile acid-sensitive bacteria and a microbiome-based biomarker for aldafermin (NGM282) in patients with non-alcoholic steatohepatitis
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.12 |
THU201 Novel metagenomic signature of fungal mycobiome in NAFLD-cirrhosis with validation in a geographically independent cohort
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.13 |
THU202 Lactobacillus rhamnosus GG improve fungal dysbiosis on liver cirrhotic rats
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.14 |
THU203 Protective effects of akkermansia muciniphila against non-alcoholic fatty liver disease through modulation of gut microbiota
|
27 August 2020 09:00 - 20:00
|
Get .iCal | |||
.15 |
THU204 Identification of gut bacterial candidates involved in hepatic encephalopathy by the analysis of feces DNA from patients administered rifaximin
|
27 August 2020 09:00 - 20:00
|
Get .iCal |